The DOI matches its Crossref record; 457 of the 457 references it cites were found in a registry or an index.
Actions of TGF-β as tumor suppressor and pro-metastatic factor in human cancer
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Items 201–400 of 457
Strutz, F., Zeisberg, M., Renziehausen, A., Raschke, B., Becker, V., Van Kooten, C., & Müller, G. A. (2001) · Kidney International · doi:10.1046/j.1523-1755.2001.059002579.x · Cited by 250
Davies, M., Robinson, M., Smith, E., Huntley, S., Prime, S., & Paterson, I. (2005) · Journal of Cellular Biochemistry · doi:10.1002/jcb.20458 · Cited by 250
Forrester, E., Chytil, A., Bierie, B., Aakre, M., Gorska, A. E., Sharif-Afshar, A.-R., Muller, W. J., & Moses, H. L. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-3272 · Cited by 249
Sun, Y., Liu, X., Ng-Eaton, E., Lodish, H. F., & Weinberg, R. A. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.22.12442 · Cited by 247
Grady, W. M., Rajput, A., Myeroff, L. L., Liu, D. F., Kwon, K., Willis, J. E., & Markowitz, S. D. (1998) · PubMed · Cited by 244
Hasegawa, Y., Takanashi, S., Kanehira, Y., Tsushima, T., Imai, T., & Okumura, K. (2001) · Cancer · doi:10.1002/1097-0142(20010301)91:5<964::aid-cncr1086>3.0.co;2-o · Cited by 244
c-myc Is a Downstream Target of the Smad Pathway
Yagi, K., Furuhashi, M., Aoki, H., Goto, D., Kuwano, H., Sugamura, K., Miyazono, K., & Kato, M. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m104170200 · Cited by 244
Somatic in vivo alterations of the DPC4 gene at 18q21 in human lung cancers.
Nagatake, M., Takagi, Y., Osada, H., Uchida, K., Mitsudomi, T., Saji, S., Shimokata, K., Takahashi, T., & Takahashi, T. (1996) · PubMed · Cited by 241
Tachibana, I., Imoto, M., Adjei, P. N., Gores, G. J., Subramaniam, M., Spelsberg, T. C., & Urrutia, R. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119418 · Cited by 241
Ehrhart, E. J., Segarini, P., Tsang, M. L. ‐., Carroll, A. G., & Barcellos‐Hoff, M. H. (1997) · The FASEB Journal · doi:10.1096/fasebj.11.12.9337152 · Cited by 236
Feng, X.-H., Liang, Y.-Y., Liang, M., Zhai, W., & Lin, X. (2002) · Molecular Cell · doi:10.1016/s1097-2765(01)00430-0 · Cited by 231
Type I Transforming Growth Factor β Receptor Binds to and Activates Phosphatidylinositol 3-Kinase
Yi, J. Y., Shin, I., & Arteaga, C. L. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m413223200 · Cited by 228
Dual role for TGF-?1 in apoptosis
SANCHEZCAPELO, A. (2005) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2004.11.002 · Cited by 228
Kamaraju, A. K., & Roberts, A. B. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m403960200 · Cited by 227
Edlund, S., Bu, S., Schuster, N., Aspenström, P., Heuchel, R., Heldin, N.-E., ten Dijke, P., Heldin, C.-H., & Landström, M. (2003) · Molecular Biology of the Cell · doi:10.1091/mbc.02-03-0037 · Cited by 226
Bourguignon, L. Y. W., Singleton, P. A., Zhu, H., & Zhou, B. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m204320200 · Cited by 224
Han, G. (2005) · Journal of Clinical Investigation · doi:10.1172/jci24399 · Cited by 224
TGF-β inhibits p70 S6 kinase via protein phosphatase 2A to induce G1 arrest
Petritsch, C., Beug, H., Balmain, A., & Oft, M. (2000) · Genes & Development · doi:10.1101/gad.854200 · Cited by 223
A crucial function of PDGF in TGF-β-mediated cancer progression of hepatocytes
Gotzmann, J., Fischer, A. N. M., Zojer, M., Mikula, M., Proell, V, Huber, H., Jechlinger, M., Waerner, T., Weith, A., Beug, H., et al. (2006) · Oncogene · doi:10.1038/sj.onc.1209083 · Cited by 223
Frederick, J. P., Liberati, N. T., Waddell, D. S., Shi, Y., & Wang, X.-F. (2004) · Molecular and Cellular Biology · doi:10.1128/mcb.24.6.2546-2559.2004 · Cited by 221
Smad3 recruits the anaphase-promoting complex for ubiquitination and degradation of SnoN
Stroschein, S. L., Bonni, S., Wrana, J. L., & Luo, K. (2001) · Genes & Development · doi:10.1101/gad.912901 · Cited by 218
Xie, W. Q., Mertens, J. C., Reiss, D. J., Rimm, D. L., Camp, R. L., Haffty, B. G., & Reiß, M. (2002) · PubMed · Cited by 217
Grände, M., Franzen, A., Karlsson, J.-O., Ericson, L. E., Heldin, N.-E., & Nilsson, M. (2002) · Journal of Cell Science · doi:10.1242/jcs.00091 · Cited by 215
Garrigue‐Antar, L., Muñoz-Antonia, T., Antonia, S. J., Gesmonde, J. F., Vellucci, V. F., & Reiss, M. (1995) · PubMed · Cited by 214
Shariat, S. F., Shalev, M., Menesses-Diaz, A., Kim, I. Y., Kattan, M. W., Wheeler, T. M., & Slawin, K. M. (2001) · Journal of Clinical Oncology · doi:10.1200/jco.2001.19.11.2856 · Cited by 214
Valdés, F., Alvarez, A. M., Locascio, A., Vega, S., Herrera, B. M., Fernández, M., Benito, M., Nieto, M. A., & Fabregat, I. (2002) · PubMed · Cited by 211
Elucidation of Smad Requirement in Transforming Growth Factor-β Type I Receptor-induced Responses
Itoh, S., Thorikay, M., Kowanetz, M., Moustakas, A., Itoh, F., Heldin, C.-H., & ten Dijke, P. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m208258200 · Cited by 209
Self-citationStructural Basis of Heteromeric Smad Protein Assembly in TGF-β Signaling
Chacko, B. M., Qin, B. Y., Tiwari, A., Shi, G., Lam, S., Hayward, L. J., de Caestecker, M., & Lin, K. (2004) · Molecular Cell · doi:10.1016/j.molcel.2004.07.016 · Cited by 209
Dalal, B. I., Keown, P. A., & Greenberg, A. H. (1993) · PubMed · Cited by 208
Dai, J., Keller, J., Zhang, J., Lu, Y., Yao, Z., & Keller, E. T. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-1891 · Cited by 208
TGF-β1 as an Enhancer of Fas-Mediated Apoptosis of Lung Epithelial Cells
Hagimoto, N., Kuwano, K., Inoshima, I., Yoshimi, M., Nakamura, N., Fujita, M., Maeyama, T., & Hara, N. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.168.12.6470 · Cited by 207
Woodford-Richens, K. L., Rowan, A. J., Gorman, P., Halford, S., Bicknell, D. C., Wasan, H. S., Roylance, R. R., Bodmer, W. F., & Tomlinson, I. P. M. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.171321498 · Cited by 199
Gastric and duodenal polyps in Smad4 (Dpc4) knockout mice.
Takaku, K., Miyoshi, H., Matsunaga, A., Oshima, M., Sasaki, N., & Taketo, M. M. (1999) · PubMed · Cited by 198
Schiffer, M., Mundel, P., Shaw, A. S., & Böttinger, E. P. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m403534200 · Cited by 198
Xu, J., & Attisano, L. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.9.4820 · Cited by 197
Lu, S.-L., Reh, D., Li, A. G., Woods, J., Corless, C. L., Kulesz-Martin, M., & Wang, X.-J. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-1032 · Cited by 197
Böttinger, E. P., Jakubczak, J. L., Haines, D. C., Bagnall, K. M., & Wakefield, L. M. (1997) · PubMed · Cited by 196
Targeted tumor therapy with the TGF-β2 antisense compound AP 12009
SCHLINGENSIEPEN, K., SCHLINGENSIEPEN, R., STEINBRECHER, A., HAU, P., BOGDAHN, U., FISCHERBLASS, B., & JACHIMCZAK, P. (2006) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2005.09.002 · Cited by 195
Tuxhorn, J. A., McAlhany, S. J., Yang, F., Dang, T. D., & Rowley, D. R. (2002) · PubMed · Cited by 195
p53-Independent Role of MDM2 in TGF-β1 Resistance
Sun, P., Dong, P., Dai, K., Hannon, G. J., & Beach, D. (1998) · Science · doi:10.1126/science.282.5397.2270 · Cited by 195
Xu, W., Angelis, K., Danielpour, D., Haddad, M. M., Bischof, O., Campisi, J., Stavnezer, E., & Medrano, E. E. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.090097797 · Cited by 194
Axin is a scaffold protein in TGF‐β signaling that promotes degradation of Smad7 by Arkadia
Liu, W., Rui, H., Wang, J., Lin, S., He, Y., Chen, M., Li, Q., Ye, Z., Zhang, S., Chan, S. C., et al. (2006) · The EMBO Journal · doi:10.1038/sj.emboj.7601057 · Cited by 193
Muraoka, R. S., Koh, Y., Roebuck, L. R., Sanders, M. E., Brantley-Sieders, D., Gorska, A. E., Moses, H. L., & Arteaga, C. L. (2003) · Molecular and Cellular Biology · doi:10.1128/mcb.23.23.8691-8703.2003 · Cited by 191
Chi, X.-Z., Yang, J.-O., Lee, K.-Y., Ito, K., Sakakura, C., Li, Q.-L., Kim, H.-R., Cha, E.-J., Lee, Y.-H., Kaneda, A., et al. (2005) · Molecular and Cellular Biology · doi:10.1128/mcb.25.18.8097-8107.2005 · Cited by 189
Nawshad, A., LaGamba, D., & Hay, E. D. (2004) · Archives of Oral Biology · doi:10.1016/j.archoralbio.2004.05.007 · Cited by 188
Critical Role of Smads and AP-1 Complex in Transforming Growth Factor-β-dependent Apoptosis
Yamamura, Y., Hua, X., Bergelson, S., & Lodish, H. F. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m006023200 · Cited by 188
Brown, K. A., Aakre, M. E., Gorska, A. E., Price, J. O., Eltom, S. E., Pietenpol, J. A., & Moses, H. L. (2004) · Breast Cancer Research · doi:10.1186/bcr778 · Cited by 187
Chen, R.-H., Su, Y.-H., Chuang, R. L., & Chang, T.-Y. (1998) · Oncogene · doi:10.1038/sj.onc.1202111 · Cited by 186
Novel roles of Akt and mTOR in suppressing TGF‐β/ALK5‐mediated Smad3 activation
Song, K., Wang, H., Krebs, T. L., & Danielpour, D. (2006) · The EMBO Journal · doi:10.1038/sj.emboj.7600917 · Cited by 185
Portella, G., Cumming, S. A., Liddell, J., Cui, W., Ireland, H., Akhurst, R. J., & Balmain, A. (1998) · PubMed · Cited by 185
Gotzmann, J., Huber, H., Thallinger, C., Wolschek, M., Jansen, B., Schulte-Hermann, R., Beug, H., & Mikulits, W. (2002) · Journal of Cell Science · doi:10.1242/jcs.115.6.1189 · Cited by 185
Slug is an Essential Target of TGFβ2 Signaling in the Developing Chicken Heart
Romano, L. A., & Runyan, R. B. (2000) · Developmental Biology · doi:10.1006/dbio.2000.9750 · Cited by 184
The mitochondrial ARTS protein promotes apoptosis through targeting XIAP
Gottfried, Y., Rotem, A., Lotan, R., Steller, H., & Larisch, S. (2004) · The EMBO Journal · doi:10.1038/sj.emboj.7600155 · Cited by 184
Friedl, W., Uhlhaas, S., Schulmann, K., Stolte, M., Loff, S., Back, W., Mangold, E., Stern, M., Knaebel, H.-P., Sutter, C., et al. (2002) · Human Genetics · doi:10.1007/s00439-002-0748-9 · Cited by 181
Regulation of Smad signaling by protein kinase C
Yakymovych, I., Dijke, P. T., Heldin, C., & Souchelnytskyi, S. (2001) · The FASEB Journal · doi:10.1096/fj.00-0474fje · Cited by 180
Shin, I., Bakin, A. V., Rodeck, U., Brunet, A., & Arteaga, C. L. (2001) · Molecular Biology of the Cell · doi:10.1091/mbc.12.11.3328 · Cited by 178
Tian, F., Byfield, S. D., Parks, W. T., Yoo, S. S., Felici, A., Tang, B., Piek, E., Wakefield, L. M., & Roberts, A. B. (2003) · PubMed · Cited by 177
Elevated plasma levels of TGF-β1 in patients with invasive prostate cancer
Ivanovic, V., Melman, A., Davis-Joseph, B., Valcic, M., & Geliebter, J. (1995) · Nature Medicine · doi:10.1038/nm0495-282 · Cited by 176
Smad-dependent GADD45beta expression mediates delayed activation of p38 MAP kinase by TGF-beta
Takekawa, M. (2002) · The EMBO Journal · doi:10.1093/emboj/cdf643 · Cited by 175
The Anaphase-Promoting Complex Mediates TGF-β Signaling by Targeting SnoN for Destruction
Wan, Y., Liu, X., & Kirschner, M. W. (2001) · Molecular Cell · doi:10.1016/s1097-2765(01)00382-3 · Cited by 169
Bone morphogenetic protein 2 (BMP-2) and induction of tumor angiogenesis
Raida, M., Clement, J. H., Leek, R. D., Ameri, K., Bicknell, R., Niederwieser, D., & Harris, A. L. (2005) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-005-0024-1 · Cited by 169
Activin/TGF-β induce apoptosis through Smad-dependent expression of the lipid phosphatase SHIP
Valderrama-Carvajal, H., Cocolakis, E., Lacerte, A., Lee, E.-H., Krystal, G., Ali, S., & Lebrun, J.-J. (2002) · Nature Cell Biology · doi:10.1038/ncb885 · Cited by 169
Smad2 and Smad4 gene mutations in hepatocellular carcinoma
Yakicier, M. C., Irmak, M. B., Romano, A., Kew, M., & Ozturk, M. (1999) · Oncogene · doi:10.1038/sj.onc.1202866 · Cited by 167
p53-dependent repression of CDK4 translation in TGF-beta-induced G1 cell-cycle arrest.
Ewen, M. E., Oliver, C. J., Sluss, H. K., Miller, S. J., & Peeper, D. S. (1995) · Genes & Development · doi:10.1101/gad.9.2.204 · Cited by 166
Benckert, C., Jonas, S., Cramer, T., von Marschall, Z., Schäfer, G., Peters, M., Wagner, K., Radke, C., Wiedenmann, B., Neuhaus, P., et al. (2003) · PubMed · Cited by 164
Loss of Smad3 in Acute T-Cell Lymphoblastic Leukemia
Wolfraim, L. A., Fernandez, T. M., Mamura, M., Fuller, W. L., Kumar, R., Cole, D. E., Byfield, S., Felici, A., Flanders, K. C., Walz, T. M., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa031197 · Cited by 163
Atfi, A., Buisine, M., Mazars, A., & Gespach, C. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.40.24731 · Cited by 162
Exploring the tumour environment: cancer-associated fibroblasts as targets in cancer therapy
Micke, P., & Östman, A. (2005) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.9.6.1217 · Cited by 162
Axin Facilitates Smad3 Activation in the Transforming Growth Factor β Signaling Pathway
Furuhashi, M., Yagi, K., Yamamoto, H., Furukawa, Y., Shimada, S., Nakamura, Y., Kikuchi, A., Miyazono, K., & Kato, M. (2001) · Molecular and Cellular Biology · doi:10.1128/mcb.21.15.5132-5141.2001 · Cited by 162
Kurisaki, K., Kurisaki, A., Valcourt, U., Terentiev, A. A., Pardali, K., ten Dijke, P., Heldin, C.-H., Ericsson, J., & Moustakas, A. (2003) · Molecular and Cellular Biology · doi:10.1128/mcb.23.13.4494-4510.2003 · Cited by 162
Self-citationDe Wever, O., Westbroek, W., Verloes, A., Bloemen, N., Bracke, M., Gespach, C., Bruyneel, E., & Mareel, M. (2004) · Journal of Cell Science · doi:10.1242/jcs.01322 · Cited by 160
Role of p300, a transcriptional coactivator, in signalling of TGF‐β
Nishihara, A., Hanai, J., Okamoto, N., Yanagisawa, J., Kato, S., Miyazono, K., & Kawabata, M. (1998) · Genes to Cells · doi:10.1046/j.1365-2443.1998.00217.x · Cited by 159
Muraoka-Cook, R. S., Kurokawa, H., Koh, Y., Forbes, J. T., Roebuck, L. R., Barcellos-Hoff, M. H., Moody, S. E., Chodosh, L. A., & Arteaga, C. L. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-2111 · Cited by 159
TGFβ-induced downregulation of E-cadherin-based cell-cell adhesion depends on PI3-kinase and PTEN
Vogelmann, R., Nguyen-tat, M.-D., Giehl, K., Adler, G., Wedlich, D., & Menke, A. (2005) · Journal of Cell Science · doi:10.1242/jcs.02594 · Cited by 159
CUTL1 is a target of TGFβ signaling that enhances cancer cell motility and invasiveness
Michl, P., Ramjaun, A. R., Pardo, O. E., Warne, P. H., Wagner, M., Poulsom, R., D’Arrigo, C., Ryder, K., Menke, A., Gress, T., et al. (2005) · Cancer Cell · doi:10.1016/j.ccr.2005.05.018 · Cited by 159
Dumont, N., Bakin, A. V., & Arteaga, C. L. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m204623200 · Cited by 159
Transforming Growth Factor-β1 Triggers Hepatocellular Carcinoma Invasiveness via α3β1 Integrin
Giannelli, G., Fransvea, E., Marinosci, F., Bergamini, C., Colucci, S. C., Schiraldi, O., & Antonaci, S. (2002) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)64170-3 · Cited by 154
Arrick, B. A., Lopez, A. R., Elfman, F., Ebner, R., Damsky, C. H., & Derynck, R. (1992) · The Journal of Cell Biology · doi:10.1083/jcb.118.3.715 · Cited by 154
Biswas, S., Chytil, A. M., Washington, K., Romero–Gallo, J., Gorska, A. E., Wirth, P. S., Gautam, S., Moses, H. L., & Grady, W. M. (2004) · Cancer Research · doi:10.1158/0008-5472.can-03-3255 · Cited by 153
Chen, T., Carter, D., Garrigue‐Antar, L., & Reiss, M. (1998) · PubMed · Cited by 150
Tsushima, H., Ito, N., Tamura, S., Matsuda, Y., Inada, M., Yabuuchi, I., Imai, Y., Nagashima, R., Misawa, H., Takeda, H., et al. (2001) · PubMed · Cited by 149
A role for Id in the regulation of TGF-β-induced epithelial–mesenchymal transdifferentiation
Kondo, M., Cubillo, E., Tobiume, K., Shirakihara, T., Fukuda, N., Suzuki, H. I., Shimizu, K., Takehara, K., Cano, A., Saitoh, M., et al. (2004) · Cell Death and Differentiation · doi:10.1038/sj.cdd.4401467 · Cited by 149
Eger, A., Stockinger, A., Park, J., Langkopf, E., Mikula, M., Gotzmann, J., Mikulits, W., Beug, H., & Foisner, R. (2004) · Oncogene · doi:10.1038/sj.onc.1207416 · Cited by 148
Karumanchi, S. A., Knebelmann, B., Grüning, W., Dhanabal, M., Walz, G., Stillman, I. E., & Sukhatme, V. P. (1999) · PubMed · Cited by 147
Invasion and metastasis of a mammary tumor involves TGF-? signaling
McEarchern, J. A., Kobie, J. J., Mack, V. E., Wu, R. S., Meade‐Tollin, L. C., Arteaga, C. L., Dumont, N., Besselsen, D. G., Seftor, E. A., Hendrix, M. J. C., et al. (2000) · International Journal of Cancer · doi:10.1002/1097-0215(20010101)91:1<76::aid-ijc1012>3.0.co;2-8 · Cited by 147
Mutations of the DPC4/Smad4 gene in biliary tract carcinoma.
Hahn, S. A., Bartsch, D. K., Schroers, A., Galehdari, H., Becker, M. A., Ramaswamy, A., Schwarte‐Waldhoff, I., Maschek, H., & Schmiegel, W. (1998) · PubMed · Cited by 146
Calonge, M. J., & Massagué, J. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.47.33637 · Cited by 144
Matsuno, F., Haruta, Y., Kondo, M., Tsai, H., Barcos, M. P., & Seon, B. K. (1999) · PubMed · Cited by 144
Nicolás, F. J., & Hill, C. S. (2003) · Oncogene · doi:10.1038/sj.onc.1206420 · Cited by 144
Bakin, A. V., Safina, A. F., Rinehart, C., Daroqui, C., Darbary, H. K., & Helfman, D. M. (2004) · Molecular Biology of the Cell · doi:10.1091/mbc.e04-04-0353 · Cited by 143
Ueki, N., Nakazato, M., Ohkawa, T., Ikeda, T., Amuro, Y., Hada, T., & Higashino, K. (1992) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/0167-4889(92)90201-l · Cited by 142
Transforming growth factor-beta1 mediates cellular response to DNA damage in situ.
Ewan, K., Henshall-Powell, R. L., Ravani, S. A., Pajares, M. J., Arteaga, C. L., Warters, R., Akhurst, R. J., & Barcellos‐Hoff, M. H. (2002) · PubMed · Cited by 142
Arsura, M., Panta, G. R., Bilyeu, J. D., Cavin, L. G., Sovak, M. A., Oliver, A. A., Factor, V. M., Heuchel, R. L., Mercurio, F., Thorgeirsson, S. S., et al. (2003) · Oncogene · doi:10.1038/sj.onc.1206132 · Cited by 141
Hofmann, T. G., Stollberg, N., Schmitz, M. L., & Will, H. (2003) · PubMed · Cited by 140
Knaus, P. I., Lindemann, D., DeCoteau, J. F., Perlman, R., Yankelev, H., Hille, M., Kadin, M. E., & Lodish, H. F. (1996) · Molecular and Cellular Biology · doi:10.1128/mcb.16.7.3480 · Cited by 140
Muraoka-Cook, R. S., Shin, I., Yi, J. Y., Easterly, E., Barcellos‐Hoff, M. H., Yingling, J. M., Zent, R., & Arteaga, C. L. (2005) · Oncogene · doi:10.1038/sj.onc.1208964 · Cited by 139
Smad3 allostery links TGF-β receptor kinase activation to transcriptional control
Qin, B. Y., Lam, S. S., Correia, J. J., & Lin, K. (2002) · Genes & Development · doi:10.1101/gad.1002002 · Cited by 139
ACVR1B ( ALK4 , activin receptor type 1B) gene mutations in pancreatic carcinoma
Su, G. H., Bansal, R. K., Murphy, K. M., Montgomery, E. A., Yeo, C. J., Hruban, R. H., & Kern, S. E. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.051484398 · Cited by 139
Arteaga, C. L., Dugger, T. C., Moses, H. L., Hurd, S. D., & Pietenpol, J. A. (1993) · PubMed · Cited by 139
Diverse Biological Effect and Smad Signaling of Bone Morphogenetic Protein 7 in Prostate Tumor Cells
Yang, S., Zhong, C., Frenkel, B., Reddi, A. H., & Roy‐Burman, P. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-0289 · Cited by 138
Krasagakis, K., Thölke, D., Farthmann, B., Eberle, J., Mansmann, U., & Orfanos, C. E. (1998) · British Journal of Cancer · doi:10.1038/bjc.1998.245 · Cited by 138
Elevated serum levels of transforming growth factor-?1 in patients with colorectal carcinoma
Shim, K. S., Kim, K. H., Han, W. S., & Park, E. B. (1999) · Cancer · doi:10.1002/(sici)1097-0142(19990201)85:3<554::aid-cncr6>3.0.co;2-x · Cited by 138
Subramanian, G., Schwarz, R. E., Higgins, L., McEnroe, G., Chakravarty, S., Dugar, S., & Reiss, M. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-0018 · Cited by 138
Gohongi, T., Fukumura, D., Boucher, Y., Yun, C., Soff, G. A., Compton, C. C., Todoroki, T., & Jain, R. K. (1999) · Nature Medicine · doi:10.1038/13524 · Cited by 136
Kang, S. H., Bang, Y., Im, Y., Yang, H.-K., Lee, D. A., Lee, H. Y., Lee, H. S., Kim, N. K., & Kim, S. (1999) · Oncogene · doi:10.1038/sj.onc.1203146 · Cited by 136
Identification of phosphatases for Smad in the BMP/DPP pathwayPreprint
Chen, H. B., Shen, J., Ip, Y. T., & Xu, L. (2006) · Genes & Development · doi:10.1101/gad.1384706 · Cited by 136
Xie, L., Law, B. K., Aakre, M. E., Edgerton, M. E., Shyr, Y., Bhowmick, N. A., & Moses, H. L. (2003) · Breast Cancer Research · doi:10.1186/bcr640 · Cited by 134
Smad7 mediates apoptosis induced by transforming growth factor β in prostatic carcinoma cells
Landström, M., Heldin, N., Bu, S., Hermansson, A., Itoh, S., ten Dijke, P., & Heldin, C. (2000) · Current Biology · doi:10.1016/s0960-9822(00)00470-x · Cited by 133
Stampfer, M. R., Garbe, J. C., Levine, G. A., Lichtsteiner, S., Vasserot, A. P., & Yaswen, P. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.071483998 · Cited by 133
Bone morphogenetic protein 2 stimulation of tumor growth involves the activation of Smad-1/5
Langenfeld, E. M., Kong, Y., & Langenfeld, J. E. (2005) · Oncogene · doi:10.1038/sj.onc.1209110 · Cited by 132
Loss of the Smad3 expression increases susceptibility to tumorigenicity in human gastric cancer
Han, S., Kim, H.-T., Seong, D. H., Kim, Y. S., Park, Y., Bang, Y., Yang, H., & Kim, S. (2003) · Oncogene · doi:10.1038/sj.onc.1207259 · Cited by 131
Kanamoto, T., Hellman, U., Heldin, C., & Souchelnytskyi, S. (2002) · The EMBO Journal · doi:10.1093/emboj/21.5.1219 · Cited by 130
Alexandrow, M. G., Kawabata, M., Aakre, M. E., & Moses, H. L. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.8.3239 · Cited by 130
Fukuchi, M., Fukai, Y., Masuda, N., Miyazaki, T., Nakajima, M., Sohda, M., Manda, R., Tsukada, K., Kato, H., & Kuwano, H. (2002) · PubMed · Cited by 127
Reed, J. A., Bales, E. S., Xu, W., Okan, N. A., Bandyopadhyay, D., & Medrano, E. E. (2001) · PubMed · Cited by 127
Griswold‐Prenner, I., Kamibayashi, C., Maruoka, E. M., Mumby, M. C., & Derynck, R. (1998) · Molecular and Cellular Biology · doi:10.1128/mcb.18.11.6595 · Cited by 127
Bhowmick, N. A., Ghiassi, M., Aakre, M. E., Brown, K., Singh, V., & Moses, H. L. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2536483100 · Cited by 124
A Transforming Growth Factor β-Induced Smad3/Smad4 Complex Directly Activates Protein Kinase A
Zhang, L., Duan, C. J., Binkley, C. E., Li, G., Uhler, M. D., Logsdon, C. D., & Simeone, D. M. (2004) · Molecular and Cellular Biology · doi:10.1128/mcb.24.5.2169-2180.2004 · Cited by 124
Wang, D., Kanuma, T., Mizunuma, H., Takama, F., Ibuki, Y., Wake, N., Mogi, A., Shitara, Y., & Takenoshita, S. (2000) · PubMed · Cited by 121
Inducible expression of transforming growth factor beta1 in papillomas causes rapid metastasis.
Weeks, B. H., He, W., Olson, K. L., & Wang, X. J. (2001) · PubMed · Cited by 120
Prunier, C., & Howe, P. H. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m500974200 · Cited by 120
Shim, C., Zhang, W., Rhee, C. H., & Lee, J. H. (1998) · PubMed · Cited by 119
Snail family members and cell survival in physiological and pathological cleft palates
Martínez‐Álvarez, C., Blanco, M. J., Pérez-Gómez, R., Rabadán, M. A., Aparicio, M. E., Resel, E., Martı́nez, T., & Nieto, M. A. (2003) · Developmental Biology · doi:10.1016/j.ydbio.2003.09.022 · Cited by 119
Transforming Growth Factor β Triggers Two Independent-Senescence Programs in Cancer Cells
Katakura, Y., Nakata, E., Miura, T., & Shirahata, S. (1999) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1999.0129 · Cited by 117
Glick, A. B., Weinberg, W. C., Wu, I. H., Quan, W., & Yuspa, S. H. (1996) · PubMed · Cited by 117
Smad7 induces tumorigenicity by blocking TGF-β-induced growth inhibition and apoptosis
Halder, S. K., Beauchamp, R. D., & Datta, P. K. (2005) · Experimental Cell Research · doi:10.1016/j.yexcr.2005.03.009 · Cited by 116
Suzuki, H., Yagi, K., Kondo, M., Kato, M., Miyazono, K., & Miyazawa, K. (2004) · Oncogene · doi:10.1038/sj.onc.1207690 · Cited by 116
Shen, X., Li, J., Hu, P. P.-C., Waddell, D. S., Zhang, J., & Wang, X. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m009534200 · Cited by 116
Hempen, P. M., Zhang, L., Bansal, R. K., Iacobuzio–Donahue, C. A., Murphy, K. M., Maitra, A., Vogelstein, B., Whitehead, R. H., Markowitz, S. D., Willson, J. K. V., et al. (2003) · PubMed · Cited by 115
Ewan, K., Oketch‐Rabah, H. A., Ravani, S. A., Shyamala, G., Moses, H. L., & Barcellos‐Hoff, M. H. (2005) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)62985-9 · Cited by 115
Effect of Smad7 Expression on Metastasis of Mouse Mammary Carcinoma JygMC(A) Cells
Azuma, H., Ehata, S., Miyazaki, H., Watabe, T., Maruyama, O., Imamura, T., Sakamoto, T., Kiyama, S., Kiyama, Y., Ubai, T., et al. (2005) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/dji399 · Cited by 115
Bandyopadhyay, A. M., Zhu, Y., Cibull, M. L., Bao, L., Chen, C., & Sun, L. (1999) · PubMed · Cited by 115
Gorska, A. E., Joseph, H., Derynck, R., Moses, H. L., & Serra, R. A. (1998) · PubMed · Cited by 115
Loss of BMP2, Smad8, and Smad4 expression in prostate cancer progression
Horvath, L. G., Henshall, S. M., Kench, J. G., Turner, J., Golovsky, D., Brenner, P. C., O’Neill, G., Kooner, R., Stricker, P. D., Grygiel, J. J., et al. (2003) · The Prostate · doi:10.1002/pros.10361 · Cited by 114
Brodin, G., ten Dijke, P., Funa, K., Heldin, C., & Landström, M. (1999) · PubMed · Cited by 114
Chang, H. L., Gillett, N. A., Figari, I. S., Lopez, A. R., Palladino, M. A., & Derynck, R. (1993) · PubMed · Cited by 113
Smad pathway‐specific transcriptional regulation of the cell cycle inhibitor p21WAF1/Cip1
Pardali, K., Kowanetz, M., Heldin, C., & Moustakas, A. (2005) · Journal of Cellular Physiology · doi:10.1002/jcp.20304 · Cited by 112
Self-citationHe, J., Tegen, S. B., Krawitz, A. R., Martin, G. S., & Luo, K. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m304016200 · Cited by 111
Ohgushi, M., Kuroki, S., Fukamachi, H., O’Reilly, L. A., Kuida, K., Strasser, A., & Yonehara, S. (2005) · Molecular and Cellular Biology · doi:10.1128/mcb.25.22.10017-10028.2005 · Cited by 109
Park, B.-J., Park, J., Byun, D.-S., Park, J. H., & Chi, S. G. (2000) · PubMed · Cited by 109
Kim, B.-C., Mamura, M., Choi, K. S., Calabretta, B., & Kim, S. (2002) · Molecular and Cellular Biology · doi:10.1128/mcb.22.5.1369-1378.2002 · Cited by 107
Scaffidi, A. K., Petrovic, N., Moodley, Y. P., Fogel‐Petrovic, M., Kroeger, K. M., Seeber, R. M., Eidne, K. A., Thompson, P. J., & Knight, D. A. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m403010200 · Cited by 107
Breit, S., Ashman, K., Wilting, J., et al. (2000) · PubMed · Cited by 107
Smad7 inhibits the survival nuclear factor κB and potentiates apoptosis in epithelial cells
Lallemand, F., Mazars, A., Prunier, C., Bertrand, F., Kornprost, M., Gallea, S., Roman‐Roman, S., Cherqui, G., & Atfi, A. (2001) · Oncogene · doi:10.1038/sj.onc.1204167 · Cited by 106
E1A Inhibits Transforming Growth Factor-β Signaling through Binding to Smad Proteins
Nishihara, A., Hanai, J., Imamura, T., Miyazono, K., & Kawabata, M. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.40.28716 · Cited by 105
Kleeff, J. H., Maruyama, H., Frieß, H., Büchler, M. W., Falb, D., & Korc, M. (1999) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1999.0171 · Cited by 105
Caulı́n, C., Scholl, F. G., Frontelo, P., Gamallo, C., & Quintanilla, M. (1995) · PubMed · Cited by 105
Evidence for a Role of the JNK Cascade in Smad7-mediated Apoptosis
Mazars, A., Lallemand, F., Prunier, C., Marais, J., Ferrand, N., Pessah, M., Cherqui, G., & Atfi, A. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m101672200 · Cited by 103
Javelaud, D., Delmas, V., Möller, M., Sextius, P., André, J., Ménashi, S., Larue, L., & Mauviel, A. (2005) · Oncogene · doi:10.1038/sj.onc.1208900 · Cited by 101
Copland, J. A., Luxon, B. A., Ajani, L., Maity, T., Campagnaro, E. L., Guo, H., LeGrand, S. N., Tamboli, P., & Wood, C. G. (2003) · Oncogene · doi:10.1038/sj.onc.1206835 · Cited by 101
Peng, S.-B., Yan, L., Xia, X., Watkins, S. A., Brooks, H. B., Beight, D. W., Herron, D. K., Jones, M. L., Lampe, J. W., McMillen, W. T., et al. (2005) · Biochemistry · doi:10.1021/bi048851x · Cited by 100
Datto, M., Hu, P. P.-C., Kowalik, T. F., Yingling, J. M., & Wang, X. (1997) · Molecular and Cellular Biology · doi:10.1128/mcb.17.4.2030 · Cited by 99
Chalaux, E., López‐Rovira, T., Rosa, J. L., Pons, G., Boxer, L. M., Bartrons, R., & Ventura, F. (1999) · FEBS Letters · doi:10.1016/s0014-5793(99)01051-0 · Cited by 99
Li, W.-M., Qiao, W., Chen, L., Xu, X., Yang, X. Y., Li, D., Li, C., Brodie, S. G., Meguid, M. M., Hennighausen, L. G., et al. (2003) · Development · doi:10.1242/dev.00820 · Cited by 99
Siegel, P. M., Shu, W., & Massagué, J. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m301413200 · Cited by 98
Law, B. K., Chytil, A. M., Dumont, N., Hamilton, E. G., Waltner-Law, M. E., Aakre, M. E., Covington, C. D., & Moses, H. L. (2002) · Molecular and Cellular Biology · doi:10.1128/mcb.22.23.8184-8198.2002 · Cited by 97
Yamagata, H., Matsuzaki, K., Mori, S., Yoshida, K., Tahashi, Y., Furukawa, F., Sekimoto, G., Watanabe, T., Uemura, Y., Sakaida, N., et al. (2005) · Cancer Research · doi:10.1158/0008-5472.157.65.1 · Cited by 97
Helms, M. W., Packeisen, J., August, C., Schittek, B., Boecker, W., Brandt, B., & Buerger, H. (2005) · The Journal of Pathology · doi:10.1002/path.1785 · Cited by 96
Ito, N., Kawata, S., Tamura, S., Shirai, Y., Kiso, S., Tsushima, H., & Matsuzawa, Y. (1995) · Cancer Letters · doi:10.1016/0304-3835(95)90156-6 · Cited by 96
Shinagawa, T., Dong, H., Xu, M., Maekawa, T., & Ishii, S. (2000) · The EMBO Journal · doi:10.1093/emboj/19.10.2280 · Cited by 96
Fukuchi, M., Nakajima, M., Fukai, Y., Miyazaki, T., Masuda, N., Sohda, M., Manda, R., Tsukada, K., Kato, H., & Kuwano, H. (2004) · International Journal of Cancer · doi:10.1002/ijc.11651 · Cited by 95
SMAD7 is a prognostic marker in patients with colorectal cancer
Boulay, J., Mild, G., Lowy, A., Reuter, J., Lagrange, M., Terracciano, L., Laffer, U. T., Herrmann, R., & Rochlitz, C. F. (2003) · International Journal of Cancer · doi:10.1002/ijc.10908 · Cited by 94
Loss of Smad4 Function in Pancreatic Tumors
Maurice, D., Pierreux, C. E., Howell, M. T., Wilentz, R. E., Owen, M. J., & Hill, C. S. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m105895200 · Cited by 94
Kim, K.-Y., Kim, B.-C., Xu, Z., & Kim, S. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m313947200 · Cited by 93
Walker, R. A., Dearing, S. J., & Gallacher, B. (1994) · British Journal of Cancer · doi:10.1038/bjc.1994.228 · Cited by 92
Rowland‐Goldsmith, M., Maruyama, H., Matsuda, K., Idezawa, T., Ralli, M., Ralli, S., & Korc, M. (2002) · PubMed · Cited by 92
Prognostic significance of TGF beta 1 and TGF beta 3 in human breast carcinoma.
Ghellal, A., Li, C., Hayes, M., Byrne, G. J., Bundred, N. J., & Kumar, S. (2000) · PubMed · Cited by 90
Functional consequences of tumorigenic missense mutations in the amino-terminal domain of Smad4
Morén, A., Itoh, S., Moustakas, A., ten Dijke, P., & Heldin, C. (2000) · Oncogene · doi:10.1038/sj.onc.1203798 · Cited by 90
Self-citationInman, G. J., & Allday, M. J. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.165.5.2500 · Cited by 90
Arsura, M., Fitzgerald, M. J., Fausto, N., & Sonenshein, G. E. (1997) · PubMed · Cited by 90
Synthetic triterpenoids enhance transforming growth factor beta/Smad signaling.
Suh, N., Roberts, A. B., Reffey, S. B., Miyazono, K., Itoh, S., ten Dijke, P., Heiß, E. H., Place, A. E., Risingsong, R., Williams, C. R., et al. (2003) · PubMed · Cited by 90
Ubiquitination and Proteolysis of Cancer-Derived Smad4 Mutants by SCFSkp2
Liang, M., Liang, Y.-Y., Wrighton, K. H., Ungermannova, D., Wang, X., Brunicardi, F. C., Liu, X., Feng, X., & Lin, X. (2004) · Molecular and Cellular Biology · doi:10.1128/mcb.24.17.7524-7537.2004 · Cited by 89
Increased susceptibility to tumorigenesis of ski-deficient heterozygous mice
Shinagawa, T., Nomura, T., Colmenares, C., Ohira, M., Nakagawara, A., & Ishii, S. (2001) · Oncogene · doi:10.1038/sj.onc.1204987 · Cited by 87
Tang, Y., Katuri, V., Srinivasan, R., Fogt, F., Redman, R. S., Anand, G., Said, A. H., Fishbein, T., ZASLOFF, M. A., Reddy, E. P., et al. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-4585 · Cited by 87
Lynch, M. A., Nakashima, R., Song, H., DeGroff, V. L., Wang, D., Enomoto, T., & Weghorst, C. M. (1998) · PubMed · Cited by 86
Zhang, F., Lundin, M., Ristimaki, A. P., Heikkilä, P., Lundin, J. E., Isola, J. J., Joensuu, H., & Laiho, M. (2003) · PubMed · Cited by 86
Ishikawa, O., LeRoy, E. C., & Trojanowska, M. (1990) · Journal of Cellular Physiology · doi:10.1002/jcp.1041450124 · Cited by 86
Microarray analysis of gene expression during epithelial–mesenchymal transformation
LaGamba, D., Nawshad, A., & Hay, E. D. (2005) · Developmental Dynamics · doi:10.1002/dvdy.20489 · Cited by 86
Mäkelä, T. P., Alitalo, R., Paulsson, Y., Westermark, B., Heldin, C., & Alitalo, K. K. (1987) · Molecular and Cellular Biology · doi:10.1128/mcb.7.10.3656 · Cited by 86
Tang, B., de Castro, K. J. D., Barnes, H. E., Parks, W. T., Stewart, L. V., Böttinger, E. P., Danielpour, D., & Wakefield, L. M. (1999) · PubMed · Cited by 84
Danielpour, D. (1999) · Journal of Cell Science · doi:10.1242/jcs.112.2.169 · Cited by 84
Keski‐Oja, J., Koli, K. M., & von Melchner, H. (2004) · Trends in Cell Biology · doi:10.1016/j.tcb.2004.10.003 · Cited by 83
Panopoulou, E., Murphy, C., Rasmussen, H., Bagli, E., Rofstad, E. K., & Fotsis, T. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-2828 · Cited by 83
Osada, H., Tatematsu, Y., Masuda, A., Saito, T., Sugiyama, M., Yanagisawa, K., & Takahashi, T. (2001) · PubMed · Cited by 83
Smad3 Knockout Mice Exhibit a Resistance to Skin Chemical Carcinogenesis
Li, A. G., Lu, S., Zhang, M., Deng, C., & Wang, X. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-1331 · Cited by 82
Kim, S. G., Jong, H.-S., Kim, T.-Y., Lee, S. E., Kim, N. K., Hong, S. H., & Bang, Y. (2003) · Molecular Biology of the Cell · doi:10.1091/mbc.e03-04-0201 · Cited by 82
Tian, F., Byfield, S. D., Parks, W. T., Stuelten, C. H., Nemani, D., Zhang, Y. E., & Roberts, A. B. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-0030 · Cited by 82
Genomic structure of the human Smad3 gene and its infrequent alterations in colorectal cancers
Arai, T., Akiyama, Y., Okabe, S., Ando, M., Endo, M., & Yuasa, Y. (1998) · Cancer Letters · doi:10.1016/s0304-3835(97)00384-4 · Cited by 81
Krakowski, A., Laboureau, J., Mauviel, A., Bissell, M. J., & Luo, K. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0504107102 · Cited by 80
He, W., Cao, T., Smith, D. A., Myers, T. E., & Wang, X. (2001) · Oncogene · doi:10.1038/sj.onc.1204117 · Cited by 80
PKCα mediates TGFβ-induced growth inhibition of human keratinocytes via phosphorylation of S100C/A11
Sakaguchi, M., Miyazaki, M., Sonegawa, H., Kashiwagi, M., Ohba, M., Kuroki, T., Namba, M., & Huh, N.-H. (2004) · The Journal of Cell Biology · doi:10.1083/jcb.200312041 · Cited by 80
Hamamoto, T., Beppu, H., Okada, H., Kawabata, M., Kitamura, T., Miyazono, K., & Kato, M. (2002) · PubMed · Cited by 79
Boulay, J.-L., Mild, G., Lowy, A. J., Reuter, J., Lagrange, M., Terracciano, L., Laffer, U. T., Herrmann, R., & Rochlitz, C. F. (2002) · British Journal of Cancer · doi:10.1038/sj.bjc.6600511 · Cited by 79
Bosscher, K. D., Hill, C. S., & Nicolás, F. J. (2004) · Biochemical Journal · doi:10.1042/bj20031886 · Cited by 79
Go, C., Li, P., & Wang, X. (1999) · PubMed · Cited by 79
Smad4-independent regulation of p21/WAF1 by transforming growth factor-β
Ijichi, H., Otsuka, M., Tateishi, K., Ikenoue, T., Kawakami, T., Kanai, F., Arakawa, Y., Seki, N., Shimizu, K., Miyazono, K., et al. (2004) · Oncogene · doi:10.1038/sj.onc.1207222 · Cited by 78
Autocrine TGFβ supports growth and survival of human breast cancer MDA-MB-231 cells
Lei, X., Bandyopadhyay, A. M., Le, T., & Sun, L. (2002) · Oncogene · doi:10.1038/sj.onc.1205966 · Cited by 77
Lücke, C. D., Philpott, A., Metcalfe, J. C., Thompson, A. M., Hughes‐Davies, L., Kemp, P. R., & Hesketh, R. (2001) · PubMed · Cited by 76
Chen, T., Wu, Y., Wells, R. G., Rimm, D. L., McNiff, J. M., Leffell, D. J., & Reiß, M. (2001) · International Journal of Cancer · doi:10.1002/ijc.1381 · Cited by 74
Saika, S., Ikeda, K., Yamanaka, O., Flanders, K. C., Ohnishi, Y., Nakajima, Y., Muragaki, Y., & Ooshima, A. (2005) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00306.2005 · Cited by 74
Cited by
Massagué, J. (2008) · Cell · doi:10.1016/j.cell.2008.07.001 · Cited by 3,907
Yuan, J.-H., Yang, F., Wang, F., Ma, J.-Z., Guo, Y.-J., Tao, Q.-F., Liu, F., Pan, W., Wang, T.-T., Zhou, C.-C., et al. (2014) · Cancer Cell · doi:10.1016/j.ccr.2014.03.010 · Cited by 1,515
Tian, T., Zhu, Y.-L., Zhou, Y.-Y., Liang, G.-F., Wang, Y.-Y., Hu, F.-H., & Xiao, Z.-D. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.588046 · Cited by 726
Integrins and the activation of latent transforming growth factor β1 – An intimate relationship
Wipff, P.-J., & Hinz, B. (2008) · European Journal of Cell Biology · doi:10.1016/j.ejcb.2008.01.012 · Cited by 517
Ion channels and the hallmarks of cancer
Prevarskaya, N., Skryma, R., & Shuba, Y. (2010) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2010.01.005 · Cited by 448
Metadata
- Authors
- Pardali, K., & Moustakas, A.
- Venue
- Biochimica et Biophysica Acta (BBA) - Reviews on Cancer
- Publisher
- Elsevier BV
- Published
- 2007-01
- Volume
- 1775
- Issue
- 1
- Pages
- 21-62
- ISSN
- 0304-419X (ISSN-L)
- OpenAlex
- W2075704804
- Cited by
- 526
- References
- 457
- FWCI
- 13.14
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.